# Vistance Networks, Inc.: Form 10-Q for the period ended Mar 31, 2026

- Company: [Vistance Networks, Inc.](/companies/visn.md) (CIK 1517228)
- Form: 10-Q
- Filed: 2026-04-30
- Accepted by EDGAR: Apr 30, 2026, 07:13 ET
- Period: 2026-03-31
- Accession: 0001193125-26-193963
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1517228/000119312526193963/visn-20260331.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1517228/000119312526193963/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2026-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2026-01-01 to 2026-03-31 | $471.8m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2026-01-01 to 2026-03-31 | $238.1m | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2026-01-01 to 2026-03-31 | $233.7m | us-gaap:GrossProfit |
| Research and development | 3 months, 2026-01-01 to 2026-03-31 | $58.2m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2026-01-01 to 2026-03-31 | $109.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2026-01-01 to 2026-03-31 | $23.7m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2026-01-01 to 2026-03-31 | −$185.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2026-01-01 to 2026-03-31 | $5.51bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2026-01-01 to 2026-03-31 | $23.15 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2026-01-01 to 2026-03-31 | $24.45 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2026-01-01 to 2026-03-31 | 237,900,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2026-01-01 to 2026-03-31 | −$226.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2026-01-01 to 2026-03-31 | $2.2m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2026-03-31 | $2.51bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2026-03-31 | $3.32bn | us-gaap:AssetsCurrent |
| Total assets | at 2026-03-31 | $5.44bn | us-gaap:Assets |
| Current liabilities | at 2026-03-31 | $498.6m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2026-03-31 | $848.5m | us-gaap:Liabilities |
| Long-term debt | at 2026-03-31 | $0 | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2026-03-31 | $0 | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2026-03-31 | $4.59bn | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 42,170 characters.

The following narrative is an analysis of the three months ended March 31, 2026 compared to the three months ended March 31, 2025. The discussion is provided to increase the understanding of, and should be read in conjunction with, the unaudited condensed consolidated financial statements and accompanying notes included in this report, as well as the audited consolidated financial statements, related notes thereto and management’s discussion and analysis of financial condition and results of operations, including management’s discussion and analysis regarding the application of critical accounting policies and the risk factors in our Annual Report on Form 10-K for the year ended December 31, 2025 (2025 Annual Report).

We discuss certain financial measures in management’s discussion and analysis of financial condition and results of operations, including adjusted EBITDA, that differ from measures calculated in accordance with generally accepted accounting principles (GAAP) in the United States (U.S.). See “Reconciliation of Non-GAAP Measures” included below for more information about these non-GAAP financial measures, including our reasons for including the measures and material limitations with respect to the usefulness of the measures.

### Overview

We are a global provider of infrastructure solutions for communication, data center and entertainment networks. Our solutions for wired and wireless networks enable service providers, including cable, telephone and digital broadcast satellite operators and media programmers, to deliver media, voice, Internet Protocol (IP) data services and Wi-Fi to their subscribers and allow enterprises to experience constant wireless and wired connectivity across complex and varied networking environments. Our solutions are complemented by services including technical support, systems design and integration. We are a leader in digital video and IP television distribution systems, broadband access infrastructure platforms and equipment that delivers data and voice networks to homes. Our global leadership position is built upon innovative technology, broad solution offerings, high-quality and cost-effective customer solutions, and global manufacturing and distribution scale.

Following the divestiture of the CCS segment that was completed on January 9, 2026, we initiated a new restructuring plan to right-size its cost structure and align operations with its revised business scope. As a result of this transaction, the new restructuring plan and our prior transformation initiative, we incurred $9.6 million and $11.2 million of net restructuring costs and $10.7 million and $4.3 million of transaction, transformation and integration costs during the three months ended March 31, 2026 and 2025, respectively. We expect to continue to incur such costs during 2026 as we continue executing on our current transformation initiative, and the resulting charges and cash requirements could be material.

In addition to the divestiture of the CCS segment, we completed the divestitures of our Home business, Outdoor Wireless Networks (OWN) segment and Distributed Antenna Systems (DAS) business unit during 2025 and 2024. Unless otherwise noted, the following discussions relate solely to our continuing operations. For further discussion of the discontinued operations related to our CCS segment, OWN segment, DAS business unit and Home business, see Note 2 in the Notes to Consolidated Financial Statements included elsewhere in the Annual Report on Form 10-K.

Our continuing operations results include general corporate costs that were previously allocated to the CCS segment, OWN segment and DAS business unit. These indirect costs, reflected on the corporate and other line item within our segment information below, are classified as continuing operations, since the costs were not directly attributable to these discontinued operations. Beginning in the first quarter of 2025, the corporate and other costs related to the OWN segment and DAS business unit have been reallocated to our remaining segments and partially offset by income from our transition service agreement with Amphenol Corporation (Amphenol TSA). The corporate and other costs related to the CCS segment have been reallocated to our remaining segments and partially offset by income from our Amphenol TSA beginning in the first quarter of 2026.

Additionally, below we refer to certain supplementary Core financial measures, which reflect the results of the RUCKUS and Aurora segments, in the aggregate, and exclude general corporate costs that were previously allocated to the CCS segment, OWN segment and DAS business unit, since these costs were not directly attributable to the discontinued operations. The Core results represent the business results as currently managed and reported by the Company. Future results and the composition of any business divested in the future may vary and differ materially from the presentation of the Core financial measures. See the “Segment Results” section below for the aggregation of our Core financial measures.

### CRITICAL ACCOUNTING POLICIES

There have been no changes in our critical accounting policies as disclosed in our 2025 Annual Report.

### COMPARISON OF RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED MARCH 31, 2026 WITH THE THREE MONTHS ENDED MARCH 31, 2025

*(dollars in millions, except per share amounts)*

|  | Three Months Ended March 31, 2026 Amount | % of Net Sales | 2025 Amount | % of Net Sales | Change | % Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Net sales | $471.8 | 100.0% | $388.1 | 100.0% | $83.7 | 21.6% |
| Gross profit | 233.7 | 49.5 | 197.6 | 50.9 | 36.1 | 18.3 |
| Operating income (loss) | 23.7 | 5.0 | (16.3) | (4.2) | 40.0 | NM |
| Core operating income (loss) (1) | 23.7 | 5.0 | 5.2 | 1.3 | 18.5 | 355.8 |
| Non-GAAP adjusted EBITDA (2) | 87.3 | 18.5 | 47.2 | 12.2 | 40.1 | 85.0 |
| Core adjusted EBITDA (1) (2) | 87.3 | 18.5 | 63.1 | 16.3 | 24.2 | 38.4 |
| Income from continuing operations | 231.7 | 49.1 | 341.1 | 87.9 | (109.4) | (32.1) |
| Diluted earnings from continuing operations per share | $0.97 |  | $1.25 |  | $(0.28) | (22.4) |
| NM – Not meaningful |  |  |  |  |  |  |

(1) Core financial measures reflect the results of the RUCKUS and Aurora segments, in the aggregate, and exclude general corporate costs that were previously allocated to the CCS segment, OWN segment and DAS business unit, since these costs were not directly attributable to these discontinued operations. Beginning in the first quarter of 2025, these costs related to the OWN segment and DAS business unit have been reallocated to our remaining segments and partially offset by income from our Amphenol TSA. These costs related to the CCS segment have been reallocated to our remaining segments and partially offset by income from our Amphenol TSA beginning in the first quarter of 2026. See “Segment Results” section below for the aggregation of our Core financial measures.

(2) See “Reconciliation of Non-GAAP Measures” in this Management’s Discussion and Analysis of Financial Condition and Results of Operations, below.

### Net sales

*(dollars in millions)*

|  | Three Months Ended March 31,% 2026 | 2025 | Change | Change |
| --- | ---: | ---: | ---: | ---: |
| Net sales | $471.8 | $388.1 | $83.7 | 21.6% |
| Domestic | 327.7 | 264.1 | 63.6 | 24.1 |
| International | 144.1 | 124.0 | 20.1 | 16.2 |

Net sales for the three months ended March 31, 2026 increased $83.7 million, or 21.6% compared to the prior year period primarily driven by increased sales volumes partially offset by lower pricing. The increase in net sales for the three months ended March 31, 2026 was driven by higher net sales of $73.4 million in the Aurora segment and $10.3 million in the RUCKUS segment.

From a regional perspective, for the three months ended March 31, 2026 compared to the prior year period, net sales increased in the U.S. by $63.6 million, the Europe, Middle East and Africa (EMEA) region by $19.3 million and the Asia Pacific (APAC) region by $14.4 million, but decreased in Canada by $9.0 million and the Caribbean and Latin America (CALA) region by $4.6 million. Net sales to customers located outside of the U.S. comprised 30.5% of total net sales for the three months ended March 31, 2026 compared to 32.0% for the three months ended March 31, 2025. Foreign exchange rate changes did not have a material impact on our net sales during the three months ended March 31, 2026 compared to the prior year period. For additional information on regional sales by segment, see “Segment Results” below and Note 6 in the Notes to Unaudited Condensed Consolidated Financial Statements included herein.

### Gross profit, TSA income, SG&A expense and R&D expense

*(dollars in millions)*

|  | Three Months Ended March 31,% 2026 | 2025 | Change | Change |
| --- | ---: | ---: | ---: | ---: |
| Gross profit | $233.7 | $197.6 | $36.1 | 18.3% |
| As a percent of sales | 49.5% | 50.9% |  |  |
| TSA income | 1.1 | 8.7 | (7.6) | (87.4) |
| As a percent of sales | 0.2% | 2.2% |  |  |
| SG&A expense | 109.2 | 108.9 | 0.3 | 0.3 |
| As a percent of sales | 23.1% | 28.1% |  |  |
| R&D expense | 58.2 | 66.2 | (8.0) | (12.1) |
| As a percent of sales | 12.3% | 17.1% |  |  |

### Gross profit (net sales less cost of sales)

Gross profit increased by $36.1 million for the three months ended March 31, 2026 compared to the prior year period primarily due to increased net sales volumes and lower input costs.

### Transition service agreement income

Transition service agreement (TSA) income is related to the TSA we entered into with Amphenol in conjunction with the closing of the transactions to divest of the CCS segment, OWN segment and DAS business unit. Under the TSAs, we provide and receive certain post-closing support on a transitional basis. The TSAs have varying terms for duration, depending on the services provided thereunder, and provide for options to extend. For additional information related to the TSAs, see Note 2 in the Notes to Unaudited Condensed Consolidated Financial Statements included herein.

### Selling, general and administrative expense

For the three months ended March 31, 2026, selling, general and administrative (SG&A) expense increased by $0.3 million, but decreased as a percentage of sales, compared to the prior year period. The increase was primarily due to increased variable incentive compensation expense of $2.2 million and higher transaction costs of $6.4 million, mostly offset by a reduction in legal expense of $6.6 million and various other costs.

### Research and development expense

Research and development (R&D) expense for three months ended March 31, 2026 decreased by $8.0 million due to lower spending within both the RUCKUS and Aurora segments, compared to the prior year period. R&D activities generally involve ensuring that our products are capable of meeting the evolving technological needs of our customers, bringing new products to market and modifying existing products to better serve our customers.

### Amortization of purchased intangible assets and Restructuring costs, net

*(dollars in millions)*

|  | Three Months Ended March 31,% 2026 | 2025 | Change | Change |
| --- | ---: | ---: | ---: | ---: |
| Amortization of purchased intangible assets | $34.1 | $36.3 | $(2.2) | (6.1)% |
| Restructuring costs, net | 9.6 | 11.2 | (1.6) | (14.3) |

### Amortization of purchased intangible assets

For the three months ended March 31, 2026, amortization of purchased intangible assets was lower compared to the prior year period because certain of our intangible assets became fully amortized.

### Restructuring costs, net

The net restructuring costs recorded in the three months ended March 31, 2026 were primarily related to our new restructuring plan to right-size our cost structure and align operations with our revised business scope. For the three months ended March 31, 2026, our net restructuring costs were $9.6 million and we paid $6.1 million to settle restructuring liabilities. We expect to make cash payments of $7.0 million in the remainder of 2026 and $0.7 million during 2027 to settle our restructuring actions. Additional restructuring actions related to our restructuring efforts are expected to be identified, and the resulting charges and cash requirements could be material.

### Other income (expense), net

*(dollars in millions)*

|  | Three Months Ended March 31,% 2026 | 2025 | Change | Change |
| --- | ---: | ---: | ---: | --- |
| Foreign currency gain (loss) | $1.1 | $(3.3) | $4.4 | NM |
| Other income (expense), net | 1.0 | (1.2) | 2.2 | NM |

### Foreign currency gain (loss)

Foreign currency gain (loss) includes the net foreign currency gains and losses resulting from the settlement of receivables and payables, foreign currency contracts and short-term intercompany advances in a currency other than the subsidiary’s functional currency. The change in foreign currency gain (loss) for the three months ended March 31, 2026 compared to the prior year period was primarily driven by certain unhedged currencies.

### Other income (expense), net

The change in other income (expense), net for the three months ended March 31, 2026 compared to the prior year period was not significant.

### Interest expense, Interest income and Income taxes

*(dollars in millions)*

|  | Three Months Ended March 31,% 2026 | 2025 | Change | Change |
| --- | ---: | ---: | ---: | ---: |
| Interest income | 20.7 | 4.4 | 16.3 | 370.5 |
| Income tax benefit | 185.2 | 357.5 | (172.3) | (48.2) |

### Interest expense and Interest income

In connection with the sale of the CCS segment that was completed on January 9, 2026, we repaid our third‑party debt at closing, and all interest expense was reported within discontinued operations. However, we expect to incur interest expense in the future. The increase in interest income compared to the prior year period was primarily driven by interest earned on the net proceeds related to the sale of the CCS segment.

### Income tax benefit

For the three months ended March 31, 2026, we recognized an income tax benefit of $185.2 million on pretax income of $46.5 million. Our income taxes were less than the statutory rate of 21.0% for the three months ended March 31, 2026, primarily due to $196.6 million of tax benefit recognized in the quarter associated with a tax planning strategy.

For the three months ended March 31, 2025, we recognized an income tax benefit of $357.5 million on a pretax loss of $16.4. Our income taxes for the three months ended March 31, 2025, were favorably impacted by $361.1 million of tax benefit recognized in the quarter associated with a tax planning strategy, as well as the tax benefit related to federal tax credits. Offsetting these benefits were the unfavorable impacts of $29.6 million of an additional valuation allowance recorded in the quarter related to current year federal and state interest limitation carryforwards and U.S. anti-deferral provisions.

### Segment Results

*(dollars in millions)*

| Net sales by segment: | Three Months Ended March 31, 2026 Amount | % of Net Sales | 2025 Amount | % of Net Sales | Change | % Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| RUCKUS | $173.4 | 36.8% | $163.1 | 42.0% | $10.3 | 6.3% |
| Aurora | 298.4 | 63.2 | 225.0 | 58.0 | 73.4 | 32.6 |
| Consolidated net sales | $471.8 | 100.0% | $388.1 | 100.0% | $83.7 | 21.6% |
| Operating income (loss) by segment: |  |  |  |  |  |  |
| RUCKUS | $8.7 | 5.0% | $7.0 | 4.3% | $1.7 | 24.3% |
| Aurora | 15.0 | 5.0 | (1.8) | (0.8) | 16.8 | NM |
| Core operating income (loss) (1) | 23.7 | 5.0 | 5.2 | 1.3 | 18.5 | 355.8 |
| Corporate and other (2) | — | NM | (21.5) | NM | 21.5 | NM |
| Consolidated operating income (loss) | $23.7 | 5.0% | $(16.3) | (4.2)% | $40.0 | NM |
| Adjusted EBITDA by segment: |  |  |  |  |  |  |
| RUCKUS (3) | $37.0 | 21.3% | $24.9 | 15.3% | $12.1 | 48.6% |
| Aurora (3) | 50.3 | 16.9 | 38.2 | 17.0 | 12.1 | 31.7 |
| Core adjusted EBITDA (1) (3) | 87.3 | 18.5 | 63.1 | 16.3 | 24.2 | 38.4 |
| Corporate and other (2) | — | NM | (15.9) | NM | 15.9 | NM |
| Non-GAAP consolidated adjusted EBITDA (3) | $87.3 | 18.5% | $47.2 | 12.2% | $40.1 | 85.0% |
| NM – Not meaningful |  |  |  |  |  |  |

(1) Core financial measures reflect the results of the RUCKUS and Aurora segments, in the aggregate, and exclude general corporate costs that were previously allocated to the CCS segment, OWN segment and DAS business unit, since these costs were not directly attributable to these discontinued operations.

(2) The corporate and other line item above primarily reflects general corporate costs that were previously allocated to the CCS segment, OWN segment and DAS business unit. These indirect expenses have been classified as continuing operations, since the costs were not directly attributable to these discontinued operations. Beginning in the first quarter of 2025, the corporate and other costs related to the OWN segment and DAS business unit have been reallocated to our remaining segments and partially offset by income from the Amphenol TSA. The corporate and other costs related to the CCS segment have been reallocated to our remaining segments and partially offset by income from the Amphenol TSA beginning in the first quarter of 2026.

(3) See “Reconciliation of Non-GAAP Measures” within this Management’s Discussion and Analysis of Financial Condition and Results of Operations.

### RUCKUS Segment

For the three months ended March 31, 2026, RUCKUS segment net sales increased compared to the prior year period primarily due to higher sales volumes, partially offset by lower pricing. From a regional perspective, for the three months ended March 31, 2026, RUCKUS segment net sales increased in the EMEA region by $14.8 million, the APAC region by $13.2 million and the CALA region by $2.2 million, but decreased in the U.S. by $19.6 million and Canada by $0.3 million, compared to the prior year period. Foreign exchange rate changes did not have a material impact on our RUCKUS segment net sales during the three months ended March 31, 2026.

For the three months ended March 31, 2026, RUCKUS segment operating income and adjusted EBITDA increased compared to the prior year period primarily due to higher sales volumes and lower R&D costs, partially offset by lower pricing and higher SG&A and input costs. RUCKUS segment operating income for the three months ended March 31, 2026, was unfavorably impacted by increases in transaction, transformation and integration costs of $7.4 million and restructuring costs of $2.9 million. Transaction, transformation and integration costs and restructuring costs are not reflected in adjusted EBITDA. See “Reconciliation of Segment Adjusted EBITDA” below.

### Aurora

For the three months ended March 31, 2026, net sales increased in the Aurora segment compared to the prior year period primarily due to higher sales volumes in Access Technologies, partially offset by lower pricing. From a regional perspective, for the three months ended March 31, 2026, Aurora segment net sales increased in the U.S. by $83.2 million, the EMEA region by $4.5 million and the APAC region by $1.2 million, but decreased in Canada by $8.7 million and the CALA region by $6.8 million, compared to the prior year period. Foreign exchange rate changes did not have a material impact on our Aurora segment net sales during the three months ended March 31, 2026.

For the three months ended March 31, 2026, Aurora segment operating income and adjusted EBITDA increased compared to the prior year period primarily due to higher sales volumes and lower R&D costs, partially offset by lower pricing, higher SG&A and input costs and unfavorable product mix. For the three months ended March 31, 2026, Aurora segment operating income was favorably impacted by reductions in amortization expense of $3.4 million, restructuring costs of $3.3 million and transaction, transformation and integration costs of $1.8 million. Amortization expense, restructuring costs and transaction, transformation and integration costs are not reflected in adjusted EBITDA. See “Reconciliation of Segment Adjusted EBITDA” below.

### LIQUIDITY AND CAPITAL RESOURCES

The following table summarizes certain key measures of our liquidity and capital resources (in millions, except percentage data):

*(dollars in millions)*

|  | March 31, 2026 | December 31, 2025 | $ Change | % Change |
| --- | ---: | ---: | ---: | ---: |
| Cash and cash equivalents (1) | $2,510.0 | $922.8 | $1,587.2 | 172.0% |
| Working capital, net of assets and liabilities held for sale (2) and excluding cash and cash equivalents | 315.2 | 5.7 | 309.5 | 5,429.8 |
| Availability under Prior Revolving Credit Facility (3) | — | 584.5 | (584.5) | (100.0) |
| Long-term debt (3) | — | 7,260.2 | (7,260.2) | (100.0) |
| Total capitalization (4) | 4,594.5 | 7,534.8 | (2,940.3) | (39.0) |
| Long-term debt as a percentage of total capitalization | — | 96.4% |  |  |

(1) Includes cash and cash equivalents in assets held for sale of $168.4 million as of December 31, 2025.

(2) Working capital is net of assets and liabilities held for sale and consists of current assets of $3,323.8 million less current liabilities of $498.6 million as of March 31, 2026 and current assets of $1,471.7 million less current liabilities of $711.6 million as of December 31, 2025.

(3) In connection with the sale of the CCS segment on January 9, 2026, on the closing date, we (i) repaid in full all outstanding indebtedness using a portion of the proceeds from the transaction and terminated all outstanding commitments under each of our Prior Revolving Credit Agreement dated as of April 4, 2019, and our Prior Term Loan Credit Agreement, dated as of December 17, 2024 and (ii) satisfied and discharged the indentures governing the Notes and redeemed all outstanding Notes on January 26, 2026 using a portion of the proceeds from the transaction.

(4) Total capitalization includes stockholders’ deficit for both periods presented, and also includes long-term debt and Series A Convertible Preferred Stock (Convertible Preferred Stock) as of December 31, 2025.

Our principal sources of liquidity on a short-term basis are cash and cash equivalents and cash flows provided by operations. On a long-term basis, our potential sources of liquidity also include raising capital through the issuance of equity and/or debt. On April 7, 2026, we entered into a revolving credit agreement providing for a senior secured asset-based revolving credit facility (the New Revolving Credit Facility) available to the Company and certain of our U.S. subsidiaries designated as co-borrowers therein, in an aggregate principal amount of up to $300.0 million, subject to borrowing base availability. See Note 8 for further discussion of the New Revolving Credit Facility.

The primary uses of liquidity include working capital requirements, capital expenditures, business separation transaction costs, transformation costs, restructuring costs, litigation settlements, income tax payments and other contractual obligations.

We currently believe that our existing cash, cash equivalents and cash flows from operations will be sufficient to meet our presently anticipated future cash needs. However, we may be required to obtain financing in the future to address our liquidity needs, and, subject to market conditions, we may from time to time seek to amend, refinance, restructure, exchange or repurchase our outstanding indebtedness and/or raise equity or other financing. Any debt we incur in the future may have terms (including cash interest rate, financial covenants and covenants limiting our operating flexibility or ability to obtain financings) that are not favorable to us, and any such equity financing may dilute the economic and/or voting interests of our existing stockholders, may be preferred in right of payment to our outstanding common stock or confer other privileges to the holders and may contain financial or operational covenants that restrict our operating flexibility or ability to obtain additional financings. Furthermore, our failure to obtain any necessary financing, or any future amendment, refinancing, restructuring, exchange or repurchases could have a material and adverse effect on our results of operations, cash flows, financial condition and liquidity.

We may experience volatility in cash flows between periods due to, among other reasons, variability in the timing of vendor payments and customer receipts. We may, from time to time, seek to obtain alternative sources of financing, by issuing debt or equity securities or incurring other indebtedness, if market conditions are favorable, utilizing trade credit, selling assets (including businesses or business lines) or securitizing receivables to meet future cash needs or to reduce our borrowing costs. Any issuance of equity or debt may be for cash or in exchange for our outstanding securities or indebtedness, or a combination thereof.

Cash and cash equivalents increased by $1,587.2 million during the three months ended March 31, 2026 as described under the Cash Flow Overview section below. As of March 31, 2026, approximately 2% of our cash and cash equivalents were held outside the U.S.

Working capital, net of assets and liabilities held for sale and excluding cash and cash equivalents, increased during the three months ended March 31, 2026 compared to the fourth quarter of 2025 primarily due to a decrease in accounts payable and other liabilities. The net decrease in total capitalization during the three months ended March 31, 2026 is primarily driven by the repayment of debt in connection with the sale of the CCS segment, partially offset by net income reflected for the period.

### Cash Flow Overview

*(dollars in millions)*

|  | Three Months Ended March 31, 2026 | 2025 | $% Change | Change |
| --- | ---: | ---: | ---: | ---: |
| Net cash used in operating activities | $(226.6) | $(186.9) | $(39.7) | 21.2% |
| Net cash generated by investing activities | 10,539.5 | 2,019.0 | 8,520.5 | 422.0 |
| Net cash used in financing activities | (8,671.5) | (2,006.2) | (6,665.3) | 332.2% |

### Operating Activities

*(in millions)*

|  | Three Months Ended March 31, 2026 | 2025 |
| --- | ---: | ---: |
| Net income | $5,508.0 | $784.0 |
| Adjustments to reconcile net income to net cash used in operating activities: |  |  |
| Depreciation and amortization | 39.1 | 78.0 |
| Equity-based compensation | 5.5 | 7.5 |
| Deferred income taxes | 1,465.5 | 13.3 |
| Gain on disposal of discontinued operations | (7,007.9) | (869.7) |
| Noncash write-off of unamortized DFF and OID | 101.3 | — |
| Changes in assets and liabilities: |  |  |
| Accounts receivable | (2.1) | (149.9) |
| Inventories | (54.7) | (35.9) |
| Prepaid expenses and other assets | (21.4) | (49.0) |
| Accounts payable and other liabilities | (274.5) | 20.5 |
| Other | 14.6 | 14.3 |
| Net cash used in operating activities | $(226.6) | $(186.9) |

During the three months ended March 31, 2026, the increase in net cash used in operating activities compared to the prior year period was driven by higher variable incentive compensation payments, partially offset by lower interest and cash taxes paid in the current year period compared to the prior year period.

### Investing Activities

*(in millions)*

|  | Three Months Ended March 31, 2026 | 2025 |
| --- | ---: | ---: |
| Additions to property, plant and equipment | $(2.2) | $(15.5) |
| Net proceeds from divestitures | 10,541.7 | 2,034.5 |
| Net cash generated by investing activities | $10,539.5 | $2,019.0 |

During the three months ended March 31, 2026, the increase in cash generated by investing activities compared to the prior year period was primarily driven by $10,460.4 million of net proceeds related to the sale of the CCS segment to Amphenol in the current year period compared to $2,034.5 million of net proceeds related to the sale of the OWN segment and DAS business unit to Amphenol in the prior year period. The net cash generated by investing activities also benefited from favorable impacts due to decreased capital expenditures of $2.2 million compared to the prior year period.

### Financing Activities

*(in millions)*

|  | Three Months Ended March 31, 2026 | 2025 |
| --- | ---: | ---: |
| Long-term debt repaid | $(7,370.8) | $(2,049.0) |
| Long-term debt proceeds | — | 50.0 |
| Debt issuance costs | — | (5.7) |
| Redemption of convertible preferred stock | (1,278.7) | — |
| Dividends paid on Series A convertible preferred stock | (1.7) | — |
| Proceeds from the issuance of common shares under equity-based compensation plans | 0.1 | — |
| Tax withholding payments for vested equity-based compensation awards | (20.4) | (1.5) |
| Net cash used in financing activities | $(8,671.5) | $(2,006.2) |

During the three months ended March 31, 2026, in connection with sale of the CCS segment, we repaid in full all outstanding indebtedness using a portion of the proceeds from the transaction which included repayment of our then-existing 2029 Term Loan in an aggregate outstanding principal amount of $3,150 million and the redemption of all outstanding Notes including (1) $1,000.0 million in outstanding aggregate principal amount of the 2031 Secured Notes, (2) $951.0 million in outstanding aggregate principal amount of the 2029 Secured Notes, (3) $641.6 million in outstanding aggregate principal amount of the 2028 Notes, (4) $866.9 million in outstanding aggregate principal amount of the 8.25% 2027 Notes and (5) $750.0 million in outstanding aggregate principal amount of the 5.00% 2027 Notes. We also recorded a loss of $11.3 million on the extinguishment of debt for the three months ended March 31, 2026. In addition, on the closing date, we redeemed 100% of the Convertible Preferred Stock for $1.3 billion of cash.

During the three months ended March 31, 2025, we repurchased $299.0 million in aggregate principal amount of our 2029 Secured Notes and repurchased in full the $1,500.0 million outstanding amount of our 2026 Secured Notes. We also borrowed $50.0 million and repaid $250.0 million of outstanding borrowings under our Prior Revolving Credit Facility during the three months ended March 31, 2025. In connection with the debt refinancing completed in December 31, 2024, we paid $5.7 million of debt issuance costs during the three months ended March 31, 2025.

During the three months ended March 31, 2026, employees surrendered shares of our common stock to satisfy their tax withholding requirements on vested restricted stock units (RSUs) and performance share units (PSUs), which reduced cash flows by $20.4 million compared to $1.5 million in the prior year period.

### Reconciliation of Non-GAAP Measures

We believe that presenting certain non-GAAP financial measures enhances an investor’s understanding of our financial performance. We further believe that these financial measures are useful in assessing our operating performance from period to period by excluding certain items that we believe are not representative of our recurring business. We also use certain of these financial measures for business planning purposes and in measuring our performance relative to that of our competitors.

We believe these financial measures are commonly used by investors to evaluate our performance and that of our competitors. However, our use of the term “non-GAAP adjusted EBITDA” may vary from that of others in our industry. These financial measures should not be considered as alternatives to operating income (loss), net income (loss) or any other performance measures derived in accordance with U.S. GAAP as measures of operating performance, operating cash flows or liquidity.

We also believe presenting these non-GAAP results for the twelve months ended March 31, 2026 provides an additional tool for assessing our recent performance. Such amounts are unaudited and are derived by subtracting the data for the three months ended March 31, 2025 from the data for the year ended December 31, 2025 and then adding the data for the three months ended March 31, 2026.

### Consolidated

*(in millions)*

|  | Three Months Ended March 31, 2026 | 2025 | Year Ended December 31, 2025 | Twelve Months Ended March 31, 2026 |
| --- | ---: | ---: | ---: | ---: |
| Income from continuing operations | $231.7 | $341.1 | $324.3 | $214.9 |
| Income tax benefit | (185.2) | (357.5) | (269.4) | (97.1) |
| Interest income | (20.7) | (4.4) | (16.7) | (33.0) |
| Other (income) expense, net | (2.1) | 4.5 | 9.4 | 2.8 |
| Operating income (loss) | 23.7 | (16.3) | 47.6 | 87.6 |
| Adjustments: |  |  |  |  |
| Amortization of purchased intangible assets | 34.1 | 36.3 | 138.4 | 136.2 |
| Restructuring costs, net | 9.6 | 11.2 | 19.7 | 18.1 |
| Equity-based compensation | 5.3 | 5.6 | 30.4 | 30.1 |
| Transaction, transformation and integration costs (1) | 10.7 | 4.3 | 29.9 | 36.3 |
| Depreciation | 3.9 | 6.1 | 21.2 | 19.0 |
| Other (2) | — | — | 4.8 | 4.8 |
| Non-GAAP adjusted EBITDA | $87.3 | $47.2 | $292.0 | $332.1 |

(1) In 2026 and 2025, primarily reflects transaction costs related to our transformation initiative that began in 2021.

(2) In 2025, reflects a pretax loss of $4.8 million related to the sale of our OneCell business.

### Reconciliation of Segment Adjusted EBITDA

Segment adjusted EBITDA is provided as a performance measure in Note 6 in the Notes to Unaudited Condensed Consolidated Financial Statements included herein. Below we reconcile segment adjusted EBITDA for each segment, individually, to operating income (loss) for that segment to supplement the reconciliation of the total segment adjusted EBITDA to consolidated operating income in Note 6.

### RUCKUS

*(in millions)*

|  | Three Months Ended March 31, 2026 | 2025 |
| --- | ---: | ---: |
| Operating income | $8.7 | $7.0 |
| Adjustments: |  |  |
| Amortization of purchased intangible assets | 12.7 | 12.7 |
| Restructuring costs, net | 4.5 | 1.6 |
| Equity-based compensation | 2.5 | 1.8 |
| Transaction, transformation and integration costs | 7.9 | 0.5 |
| Depreciation | 0.8 | 1.3 |
| Adjusted EBITDA | $37.0 | $24.9 |

### Aurora

*(in millions)*

|  | Three Months Ended March 31, 2026 | 2025 |
| --- | ---: | ---: |
| Operating income (loss) | $15.0 | $(1.8) |
| Adjustments: |  |  |
| Amortization of purchased intangible assets | 21.4 | 24.8 |
| Restructuring costs, net | 5.1 | 8.4 |
| Equity-based compensation | 2.8 | 2.0 |
| Transaction, transformation and integration costs | 2.8 | 1.0 |
| Depreciation | 3.1 | 3.9 |
| Adjusted EBITDA | $50.3 | $38.2 |

Note: Components may not sum to total due to rounding.

### FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q includes certain statements that constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which reflect our current views with respect to future events and financial performance. These forward-looking statements are generally identified by their use of such terms and phrases as “intend,” “goal,” “estimate,” “expect,” “project,” “projections,” “plans,” “potential,” “anticipate,” “should,” “could,” “designed to,” “foreseeable future,” “believe,” “think,” “scheduled,” “outlook,” “target,” “guidance” and similar expressions, although not all forward-looking statements contain such terms. This list of indicative terms and phrases is not intended to be all-inclusive.

These forward-looking statements are subject to various risks and uncertainties, many of which are outside our control, including, without limitation, the occurrence of any event, change or other circumstances that could give rise to the termination of the purchase agreement for the Ruckus transaction; the inability to complete the proposed transaction due to the failure to satisfy any of the conditions to completion of the proposed transaction, including that a governmental entity may prohibit, delay or refuse to grant approval for the consummation of the transaction; risks related to disruption of management’s attention from the Company’s ongoing business operations due to the transaction; the effect of the announcement of the proposed transaction on the Company’s relationships, operating results and business generally; the risk that the proposed transaction will not be consummated in a timely manner; exceeding the expected costs of the transaction; our dependence on customers’ capital spending on data, communication and entertainment equipment, which could be negatively impacted by a regional or global economic downturn, among other factors; the potential impact of higher than normal inflation; concentration of sales among a limited number of customers and channel partners; risks associated with our sales through channel partners; changes to the regulatory environment in which we and our customers operate; changes in technology; industry competition and the ability to retain customers through product innovation, introduction, and marketing; changes in cost and availability of key raw materials, components and commodities and the potential effect on customer pricing and timing of delivery of products to customers; risks related to our ability to implement price increases on our products and services; risks associated with our dependence on a limited number of key suppliers for certain raw materials and components; risks related to the successful execution of our transformation initiative and other cost saving initiatives; potential difficulties in realigning global manufacturing capacity and capabilities among our global manufacturing facility or those of our contract manufacturers that may affect our ability to meet customer demands for products; possible future restructuring actions; the risk that our manufacturing operations, including our contract manufacturers on which we rely, encounter capacity, production, quality, financial or other difficulties causing difficulty in meeting customer demands; our ability to incur indebtedness at acceptable interest rates or at all; our ability to generate cash to service any future indebtedness; the ability to recognize the expected benefits of the sale of the CCS segment and prior sale transactions, including the expected financial performance of Vistance Networks following the transaction and prior sale transactions; the effect of the proposed transaction and prior sale transactions on the ability of Vistance Networks to retain and hire key personnel and maintain relationships with its key business partners and customers, and others with whom it does business, or on its operating results and businesses generally; the response of Vistance Network’s competitors, creditors and prior stakeholders to the proposed transaction and prior sale transactions; potential litigation relating to the proposed transaction and prior sale transactions; our ability to integrate and fully realize anticipated benefits from prior or future divestitures, acquisitions or equity investments; possible future additional impairment charges for fixed or intangible assets, including goodwill; our ability to attract and retain qualified key employees; labor unrest; product quality or performance issues, including those associated with our suppliers or contract manufacturers, and associated warranty claims; our ability to maintain effective management information technology systems and to successfully implement major systems initiatives; cyber-security incidents, including data security breaches, ransomware or computer viruses; the use of open standards; the long-term impact of climate change; significant international operations exposing us to economic risks like variability in foreign exchange rates and inflation, as well as political and other risks, including the impact of wars, regional conflicts and terrorism; our ability to comply with governmental anti-corruption laws and regulations worldwide; the impact of export and import controls and sanctions worldwide on our supply chain and ability to compete in international markets; changes in the laws and policies in the U.S. affecting trade, including the risk and uncertainty related to tariffs or potential trade wars and potential changes to laws and policies, that may impact our products and costs; the costs of protecting or defending intellectual property; costs and challenges of compliance with domestic and foreign social and environmental laws; the impact of litigation and similar regulatory proceedings in which we are involved or may become involved, including the costs of such litigation; the scope, duration and impact of disease outbreaks and pandemics, such as COVID-19, on our business, including employees, sites, operations, customers, supply chain logistics and the global economy; our stock price volatility; income tax rate variability and ability to recover amounts recorded as deferred tax assets; and other factors beyond our control.

These and other factors are discussed in greater detail under the heading "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our 2025 Annual Report on Form 10-K and may be updated from time to time in our annual reports, quarterly reports, current reports and other filings we make with the Securities and Exchange Commission. Although the information contained in this Quarterly Report on Form 10-Q represents our best judgment as of the date of this report based on information currently available and reasonable assumptions, we can give no assurance that the expectations will be attained or that any deviation will not be material. Given these uncertainties, we caution you not to place undue reliance on these forward-looking statements, which speak only as of the date made. We are not undertaking any duty or obligation to update this information to reflect developments or information obtained after the date of this Quarterly Report on Form 10-Q, except to the extent required by law.

## Market risk

As filed, 270 characters.

There have been no material changes in the interest rate risk, commodity price risk or foreign currency exchange rate risk information previously reported under Item 7A of our 2025 Annual Report, as filed with the Securities and Exchange Commission on February 26, 2026.

## Controls and procedures

As filed, 1,311 characters.

### Disclosure Controls and Procedures

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) as of the end of the period covered by this report. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that these disclosure controls and procedures are effective.

### Changes in Internal Control Over Financial Reporting

Reference should be made to our 2025 Annual Report for additional information regarding discussion of the effectiveness of the Company’s controls and procedures. During the quarter ended March 31, 2026, the Company completed the sale of substantially all the systems and related processes of the CCS segment, resulting in the separation of its ERP system and other supporting systems. Except for the completion of the CCS segment asset migration to Amphenol and the related separation of systems, there have been no changes in our internal control over financial reporting during the quarter ended March 31, 2026 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 334 characters.

The Company’s business, financial condition, results of operations and cash flows are subject to various risks which could cause actual results to vary from recent results or from anticipated future results. There have been no material changes to the risk factors disclosed in Part I – Item 1A, Risk Factors of our 2025 Annual Report.

Filed Apr 30, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-193963. Last ingested by Listed: Nov 14, 2026, 19:07 ET. No prices; not investment advice.
